新的高效液相色谱仪将临床通量能力增加为四倍,AACC 2015展品
|
By LabMedica International staff writers Posted on 26 Oct 2015 |

图片:PreludeLX-4MD由Thermo Fisher Scientific在美国临床化学协会2015年会暨临床实验室医疗设备博览会,Booth 3135上展示,这是一种新的四通道高效液相色谱仪,将临床通量能力增加为四倍,能在一部仪器上同时平行进行4个独立的LC-MS分离,(照片由Thermo Fisher Scientific提供)。
Booth 3135召开的美国临床化学协会2015年会暨临床实验室医疗设备博览会(7月26日至30日;Atlanta,GA,USA)上展示了一种新的I类四通道HPLC仪,实验室能使用此仪器在一个设备上同时进行多个平行LC-MS分离。
Thermo Fisher Scientific Inc.(Waltham,MA,USA)现在提供了新的LX-4 MD HPLC,FDA将其列为I类医疗器械,用于一般临床使用。Prelude LX-4 MD HPLC的工作能力是单通道HPLC的四倍,在一个设备上使用四个平行的通道,能同时提供多达4个分离,简化LC-MS工作流程,减少质谱仪的空闲时间,并保持无可计平台空间。四个通道可以同时运行相同的或不同的LC-MS检测,为各种临床分离提供灵活性,并能将质谱利用率最大化。
“我们始终致力于将LC-MS检测的优势应用于临床市场,”Thermo Fisher Scientific的Bradley Hart说,“Prelude LX-4 MD是更广泛计划的首批产品之一,用于分离样品、令光谱更有效,并可供临床医生使用。
Prelude LX-4 MD是Thermo Scientific色谱和质谱设备及临床实验室软件产品家族的最新产品,该产品包括Endura MD三个四极质谱仪、Prelude MD HPLC和软件ClinQuan MD。
Related Links:
Thermo Fisher Scientific
Thermo Scientific Clinical Diagnostics
美国临床化学协会(AACC)
美国临床化学协会2015年会暨临床实验室医疗设备博览会
Thermo Fisher Scientific Inc.(Waltham,MA,USA)现在提供了新的LX-4 MD HPLC,FDA将其列为I类医疗器械,用于一般临床使用。Prelude LX-4 MD HPLC的工作能力是单通道HPLC的四倍,在一个设备上使用四个平行的通道,能同时提供多达4个分离,简化LC-MS工作流程,减少质谱仪的空闲时间,并保持无可计平台空间。四个通道可以同时运行相同的或不同的LC-MS检测,为各种临床分离提供灵活性,并能将质谱利用率最大化。
“我们始终致力于将LC-MS检测的优势应用于临床市场,”Thermo Fisher Scientific的Bradley Hart说,“Prelude LX-4 MD是更广泛计划的首批产品之一,用于分离样品、令光谱更有效,并可供临床医生使用。
Prelude LX-4 MD是Thermo Scientific色谱和质谱设备及临床实验室软件产品家族的最新产品,该产品包括Endura MD三个四极质谱仪、Prelude MD HPLC和软件ClinQuan MD。
Related Links:
Thermo Fisher Scientific
Thermo Scientific Clinical Diagnostics
美国临床化学协会(AACC)
美国临床化学协会2015年会暨临床实验室医疗设备博览会
Latest 行业新闻 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more






 Analyzer.jpg)
